These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 15073138)
1. Specific chemopreventive agents trigger proteasomal degradation of G1 cyclins: implications for combination therapy. Dragnev KH; Pitha-Rowe I; Ma Y; Petty WJ; Sekula D; Murphy B; Rendi M; Suh N; Desai NB; Sporn MB; Freemantle SJ; Dmitrovsky E Clin Cancer Res; 2004 Apr; 10(7):2570-7. PubMed ID: 15073138 [TBL] [Abstract][Full Text] [Related]
2. Cyclin proteolysis as a retinoid cancer prevention mechanism. Dragnev KH; Freemantle SJ; Spinella MJ; Dmitrovsky E Ann N Y Acad Sci; 2001 Dec; 952():13-22. PubMed ID: 11795432 [TBL] [Abstract][Full Text] [Related]
3. Cyclin D1 proteolysis: a retinoid chemoprevention signal in normal, immortalized, and transformed human bronchial epithelial cells. Boyle JO; Langenfeld J; Lonardo F; Sekula D; Reczek P; Rusch V; Dawson MI; Dmitrovsky E J Natl Cancer Inst; 1999 Feb; 91(4):373-9. PubMed ID: 10050872 [TBL] [Abstract][Full Text] [Related]
4. Retinoid targeting of different D-type cyclins through distinct chemopreventive mechanisms. Ma Y; Feng Q; Sekula D; Diehl JA; Freemantle SJ; Dmitrovsky E Cancer Res; 2005 Jul; 65(14):6476-83. PubMed ID: 16024653 [TBL] [Abstract][Full Text] [Related]
5. Inhibited transformation of immortalized human bronchial epithelial cells by retinoic acid is linked to cyclin E down-regulation. Langenfeld J; Lonardo F; Kiyokawa H; Passalaris T; Ahn MJ; Rusch V; Dmitrovsky E Oncogene; 1996 Nov; 13(9):1983-90. PubMed ID: 8934545 [TBL] [Abstract][Full Text] [Related]
6. Posttranslational regulation of cyclin D1 by retinoic acid: a chemoprevention mechanism. Langenfeld J; Kiyokawa H; Sekula D; Boyle J; Dmitrovsky E Proc Natl Acad Sci U S A; 1997 Oct; 94(22):12070-4. PubMed ID: 9342364 [TBL] [Abstract][Full Text] [Related]
7. Posttranslational mechanisms contribute to the suppression of specific cyclin:CDK complexes by all-trans retinoic acid in human bronchial epithelial cells. Sueoka N; Lee HY; Walsh GL; Hong WK; Kurie JM Cancer Res; 1999 Aug; 59(15):3838-44. PubMed ID: 10447003 [TBL] [Abstract][Full Text] [Related]
8. Evidence for the epidermal growth factor receptor as a target for lung cancer prevention. Lonardo F; Dragnev KH; Freemantle SJ; Ma Y; Memoli N; Sekula D; Knauth EA; Beebe JS; Dmitrovsky E Clin Cancer Res; 2002 Jan; 8(1):54-60. PubMed ID: 11801540 [TBL] [Abstract][Full Text] [Related]
9. Uncovering residues that regulate cyclin D1 proteasomal degradation. Feng Q; Sekula D; Müller R; Freemantle SJ; Dmitrovsky E Oncogene; 2007 Aug; 26(35):5098-106. PubMed ID: 17310991 [TBL] [Abstract][Full Text] [Related]
10. A novel retinoic acid receptor beta isoform and retinoid resistance in lung carcinogenesis. Petty WJ; Li N; Biddle A; Bounds R; Nitkin C; Ma Y; Dragnev KH; Freemantle SJ; Dmitrovsky E J Natl Cancer Inst; 2005 Nov; 97(22):1645-51. PubMed ID: 16288117 [TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor receptor tyrosine kinase inhibition represses cyclin D1 in aerodigestive tract cancers. Petty WJ; Dragnev KH; Memoli VA; Ma Y; Desai NB; Biddle A; Davis TH; Nugent WC; Memoli N; Hamilton M; Iwata KK; Rigas JR; Dmitrovsky E Clin Cancer Res; 2004 Nov; 10(22):7547-54. PubMed ID: 15569985 [TBL] [Abstract][Full Text] [Related]
12. Cancer chemoprevention by targeting proteasomal degradation: commentary re KA Dragnev et al, Specific chemopreventive agents trigger proteasomal degradation of G1 cyclins: implications for combination therapy. Clin Cancer Res, 2004;10:2570-7. Yang CS; Chin KV; Lambert JD Clin Cancer Res; 2004 Apr; 10(7):2220-1. PubMed ID: 15073095 [No Abstract] [Full Text] [Related]
13. Microarray analyses uncover UBE1L as a candidate target gene for lung cancer chemoprevention. Pitha-Rowe I; Petty WJ; Feng Q; Koza-Taylor PH; Dimattia DA; Pinder L; Dragnev KH; Memoli N; Memoli V; Turi T; Beebe J; Kitareewan S; Dmitrovsky E Cancer Res; 2004 Nov; 64(21):8109-15. PubMed ID: 15520223 [TBL] [Abstract][Full Text] [Related]
14. Uncovering novel targets for cancer chemoprevention. Dragnev KH; Feng Q; Ma Y; Shah SJ; Black C; Memoli V; Nugent W; Rigas JR; Kitareewan S; Freemantle S; Dmitrovsky E Recent Results Cancer Res; 2007; 174():235-43. PubMed ID: 17302201 [TBL] [Abstract][Full Text] [Related]
15. Cyclin degradation for cancer therapy and chemoprevention. Freemantle SJ; Liu X; Feng Q; Galimberti F; Blumen S; Sekula D; Kitareewan S; Dragnev KH; Dmitrovsky E J Cell Biochem; 2007 Nov; 102(4):869-77. PubMed ID: 17868090 [TBL] [Abstract][Full Text] [Related]
16. All-trans-retinoic acid mediates G1 arrest but not apoptosis of normal human mammary epithelial cells. Seewaldt VL; Kim JH; Caldwell LE; Johnson BS; Swisshelm K; Collins SJ Cell Growth Differ; 1997 Jun; 8(6):631-41. PubMed ID: 9185997 [TBL] [Abstract][Full Text] [Related]
17. Microarray analysis uncovers retinoid targets in human bronchial epithelial cells. Ma Y; Koza-Taylor PH; DiMattia DA; Hames L; Fu H; Dragnev KH; Turi T; Beebe JS; Freemantle SJ; Dmitrovsky E Oncogene; 2003 Jul; 22(31):4924-32. PubMed ID: 12894236 [TBL] [Abstract][Full Text] [Related]
18. Retinoid targets in cancer therapy and chemoprevention. Dragnev KH; Petty WJ; Dmitrovsky E Cancer Biol Ther; 2003; 2(4 Suppl 1):S150-6. PubMed ID: 14508093 [TBL] [Abstract][Full Text] [Related]
19. Retinoic acid-mediated G1 arrest is associated with induction of p27(Kip1) and inhibition of cyclin-dependent kinase 3 in human lung squamous carcinoma CH27 cells. Hsu SL; Hsu JW; Liu MC; Chen LY; Chang CD Exp Cell Res; 2000 Aug; 258(2):322-31. PubMed ID: 10896783 [TBL] [Abstract][Full Text] [Related]
20. Dictyostelium differentiation-inducing factor-3 activates glycogen synthase kinase-3beta and degrades cyclin D1 in mammalian cells. Takahashi-Yanaga F; Taba Y; Miwa Y; Kubohara Y; Watanabe Y; Hirata M; Morimoto S; Sasaguri T J Biol Chem; 2003 Mar; 278(11):9663-70. PubMed ID: 12522140 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]